Anemia in HS patients is a multifaceted condition often driven by both iron deficiency and chronic inflammation. Understanding the roles of hepcidin, iron sequestration, and bone marrow suppression is crucial for developing effective treatment plans. By addressing the underlying causes, including managing chronic infections like Staph A, patients can improve their quality of life and reduce the impact of anemia on their overall health.
By raising awareness about the connections between HS, anemia, and infections, we can help individuals living with HS better understand their condition and work toward more effective treatments.
